IDYA
Price
$21.37
Change
-$0.92 (-4.13%)
Updated
Jun 27 closing price
Capitalization
1.87B
45 days until earnings call
REGN
Price
$521.00
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
56.25B
34 days until earnings call
Interact to see
Advertisement

IDYA vs REGN

Header iconIDYA vs REGN Comparison
Open Charts IDYA vs REGNBanner chart's image
IDEAYA Biosciences
Price$21.37
Change-$0.92 (-4.13%)
Volume$3.2M
Capitalization1.87B
Regeneron Pharmaceuticals
Price$521.00
Change-$0.00 (-0.00%)
Volume$1.61M
Capitalization56.25B
IDYA vs REGN Comparison Chart in %
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. REGN commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and REGN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (IDYA: $21.39 vs. REGN: $521.00)
Brand notoriety: IDYA: Not notable vs. REGN: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 169% vs. REGN: 113%
Market capitalization -- IDYA: $1.87B vs. REGN: $56.25B
IDYA [@Biotechnology] is valued at $1.87B. REGN’s [@Biotechnology] market capitalization is $56.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileREGN’s FA Score has 1 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • REGN’s FA Score: 1 green, 4 red.
According to our system of comparison, REGN is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while REGN’s TA Score has 4 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 5 bearish.
  • REGN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, REGN is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а -1.29% price change this week, while REGN (@Biotechnology) price change was +2.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

REGN is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
REGN($56.3B) has a higher market cap than IDYA($1.87B). IDYA YTD gains are higher at: -16.770 vs. REGN (-26.658). REGN has higher annual earnings (EBITDA): 5.53B vs. IDYA (-356.46M). REGN has more cash in the bank: 8.35B vs. IDYA (693M). IDYA has less debt than REGN: IDYA (26M) vs REGN (2.71B). REGN has higher revenues than IDYA: REGN (14.1B) vs IDYA (7M).
IDYAREGNIDYA / REGN
Capitalization1.87B56.3B3%
EBITDA-356.46M5.53B-6%
Gain YTD-16.770-26.65863%
P/E RatioN/A13.24-
Revenue7M14.1B0%
Total Cash693M8.35B8%
Total Debt26M2.71B1%
FUNDAMENTALS RATINGS
IDYA vs REGN: Fundamental Ratings
IDYA
REGN
OUTLOOK RATING
1..100
686
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
4
Undervalued
PROFIT vs RISK RATING
1..100
69100
SMR RATING
1..100
9453
PRICE GROWTH RATING
1..100
4865
P/E GROWTH RATING
1..100
10097
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

REGN's Valuation (4) in the Biotechnology industry is somewhat better than the same rating for IDYA (62) in the null industry. This means that REGN’s stock grew somewhat faster than IDYA’s over the last 12 months.

IDYA's Profit vs Risk Rating (69) in the null industry is in the same range as REGN (100) in the Biotechnology industry. This means that IDYA’s stock grew similarly to REGN’s over the last 12 months.

REGN's SMR Rating (53) in the Biotechnology industry is somewhat better than the same rating for IDYA (94) in the null industry. This means that REGN’s stock grew somewhat faster than IDYA’s over the last 12 months.

IDYA's Price Growth Rating (48) in the null industry is in the same range as REGN (65) in the Biotechnology industry. This means that IDYA’s stock grew similarly to REGN’s over the last 12 months.

REGN's P/E Growth Rating (97) in the Biotechnology industry is in the same range as IDYA (100) in the null industry. This means that REGN’s stock grew similarly to IDYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDYAREGN
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
56%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
54%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
62%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 5 days ago
60%
Declines
ODDS (%)
Bearish Trend 6 days ago
77%
Bearish Trend 12 days ago
56%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TTD69.331.31
+1.93%
Trade Desk (The)
REVG46.540.82
+1.79%
REV Group
KNF82.771.26
+1.55%
Knife River Corp
SGHT4.290.04
+0.94%
Sight Sciences
DYAI1.00N/A
+0.30%
Dyadic International

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with IMNM. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
-4.04%
IMNM - IDYA
60%
Loosely correlated
-0.11%
CGON - IDYA
60%
Loosely correlated
-0.46%
NRIX - IDYA
58%
Loosely correlated
+0.26%
SYRE - IDYA
56%
Loosely correlated
-4.99%
CRNX - IDYA
56%
Loosely correlated
-1.22%
More

REGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, REGN has been loosely correlated with ROIV. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if REGN jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REGN
1D Price
Change %
REGN100%
N/A
ROIV - REGN
42%
Loosely correlated
-1.81%
KRYS - REGN
40%
Loosely correlated
-2.60%
VRTX - REGN
39%
Loosely correlated
-0.47%
IDYA - REGN
39%
Loosely correlated
-4.04%
SMMT - REGN
38%
Loosely correlated
-3.15%
More